​

Pasithea Therapeutics (KTTA) Revenue & Revenue Breakdown

OverviewOwnershipFinancialsChart

Pasithea Therapeutics Revenue Highlights

00

Pasithea Therapeutics Revenue by Period

Pasithea Therapeutics Revenue by Year

DateRevenueChange
2024-12-31-100.00%
2023-12-31--100.00%
2022-12-31$486.56K3130.37%
2021-12-31$15.06K100.00%
2020-12-31--

Pasithea Therapeutics generated - in revenue during NA 2024, up 100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.

Pasithea Therapeutics Revenue by Quarter

DateRevenueChange
2025-06-30-100.00%
2025-03-31--100.00%
2024-12-31$649.03K100.00%
2024-09-30-100.00%
2024-06-30-100.00%
2024-03-31--100.00%
2023-12-31$976.31K100.00%
2023-09-30-100.00%
2023-06-30-100.00%
2023-03-31--100.00%
2022-12-31$240.71K10.11%
2022-09-30$218.61K1509.66%
2022-06-30$13.58K-0.56%
2022-03-31$13.66K-9.32%
2021-12-31$15.06K100.00%
2021-09-30-100.00%
2021-06-30-100.00%
2021-03-31-100.00%
2020-12-31-100.00%
2020-09-30--

Pasithea Therapeutics generated - in revenue during Q2 2025, up 100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.

Pasithea Therapeutics Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
CYCNCyclerion Therapeutics$2.00M$875.00K
VYNEVYNE Therapeutics$501.00K$169.00K
VIVSVivoSim Labs$109.00K$24.00K
TCRTAlaunos Therapeutics$10.00K-
KALAKALA BIO--
PLRZPolyrizon--
QNRXQuoin Pharmaceuticals--
KTTAPasithea Therapeutics--

KTTA Revenue FAQ

What is Pasithea Therapeutics’s yearly revenue?

Pasithea Therapeutics's yearly revenue for 2024 was $0, representing an increase of 100.00% compared to 2023. The company's yearly revenue for 2023 was $0, representing a decrease of -100.00% compared to 2022. KTTA's yearly revenue for 2022 was $486.56K, representing an increase of 3130.37% compared to 2021.

What is Pasithea Therapeutics’s quarterly revenue?

Pasithea Therapeutics's quarterly revenue for Q2 2025 was $0, a 100.00% increase from the previous quarter (Q1 2025), and a 0% increase year-over-year (Q2 2024). The company's quarterly revenue for Q1 2025 was $0, a -100.00% decrease from the previous quarter (Q4 2024), and a 0% increase year-over-year (Q1 2024). KTTA's quarterly revenue for Q4 2024 was $649.03K, a 100.00% increase from the previous quarter (Q3 2024), and a -33.52% decrease year-over-year (Q4 2023).

What is Pasithea Therapeutics’s revenue growth rate?

Pasithea Therapeutics's revenue growth rate for the last 3 years (2022-2024) was -100.00%, and for the last 5 years (2020-2024) was 0%.